Search
Help, My Business is In Trouble! When a business becomes financially troubled, the business owner often experiences denial, paralysis, or both. Lenders commonly lose confidence and then trust in the business, as communications tend to break down, deadlines are missed, and promises are broken. Small...
EB-5 Visa 2.0: Current Trends in the Program Interest in the EB-5 program, especially among individuals in the U.S. on H-1B and F-1 visas who intend to concurrently file an EB-5 visa, is at an all-time high. While the opportunity to obtain a green card through investment was reauthorized by Congress...
Developing a Corporate AI Policy Join Association of Corporate Counsel, along with inside and outside counsel presenters, as they discuss implementing best practices and responsible use policies to manage the risk of utilizing AI in the workplace. Speakers: Matthew Kohel, Partner, Intellectual...
Since Elon Musk announced his decision to remove the iconic bird logo and adopt "X", as Twitter's new logo (the "X Logo"), the rebranding decision has been the talk of the town. The rollout has prompted a barrage of reactions and has many questioning whether the change will attract legal hurdles...
The TMA Restructuring Boot Camp is an interactive, two-part program taught by TMA Certified Turnaround Professionals (CTPs) and attorneys. The TMA Restructuring Boot Camp is a high-level overview of what it's like to parachute into a simulated distressed company to uncover the financial, management...
A recently filed class action lawsuit raises more legal challenges to providers of generative artificial intelligence (AI) tools that are used to create content. The suit cautions that a doomsday scenario is approaching and alleges a host of privacy and other violations occurring along the way. What...
Saul Ewing LLP, a full-service national law firm, is proud to announce that Bankruptcy & Restructuring Practice Vice Chair Monique B. DiSabatino was selected as one of Law360's 2023 Rising Stars. Editors reviewed more than 1,300 submissions for the Rising Star distinction, which recognizes top...
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...